← Evidence map

ArticleScientific reports2021

Anti-CD321 antibody immunotherapy protects liver against ischemia and reperfusion-induced injury.

Enzhi Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33737554